Farber Lipogranulomatosis

A sphingolipidosis subtype that is characterized by the histological appearance of granulomatous deposits in tissues. It results from the accumulation of CERAMIDES in various tissues due to an inherited deficiency of ACID CERAMIDASE.

Also Known As:

Acid Ceramidase Deficiency; Ceramidase Deficiency; Farber Disease; Farber's Disease; N-Laurylsphingosine Deacylase Deficiency; Acid Ceramidase Deficiencies; Ceramidase Deficiencies; Ceramidase Deficiency, Acid; Deficiencies, Ceramidase; Deficiencies, N-Laurylsphingosine Deacylase; Deficiency, Acid Ceramidase; Deficiency, Ceramidase; Deficiency, N-Laurylsphingosine Deacylase; Disease, Farber's; Diseases, Farber's; Farber's Diseases; Farbers Disease; Lipogranulomatosis, Farber; N Laurylsphingosine Deacylase Deficiency; N-Laurylsphingosine Deacylase Deficiencies

Nervous System Diseases: 14178
- Central Nervous System Diseases: 4213
  - Brain Diseases: 15694
    - Metabolic Brain Diseases: 215
      - Inborn Metabolic Brain Diseases: 2
        Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
Congenital, Hereditary, and Neonatal Diseases and Abnormalities: 933
- Inborn Genetic Diseases: 11939
  - Inborn Errors Metabolism: 1162
    - Lysosomal Storage Diseases: 2132
      - Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
    - Inborn Metabolic Brain Diseases: 2
      - Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
    - Inborn Errors Lipid Metabolism
      - Lipidoses: 669
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
Nutritional and Metabolic Diseases: 15
- Metabolic Diseases: 10142
  - Inborn Errors Metabolism: 1162
    - Lysosomal Storage Diseases: 2132
      - Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
    - Inborn Metabolic Brain Diseases: 2
      - Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
    - Inborn Errors Lipid Metabolism
      - Lipidoses: 669
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
  - Lipid Metabolism Disorders: 898
    - Inborn Errors Lipid Metabolism
      - Lipidoses: 669
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115
  - Metabolic Brain Diseases: 215
    - Inborn Metabolic Brain Diseases: 2
      - Nervous System Lysosomal Storage Diseases
        Sphingolipidoses: 241
        Farber Lipogranulomatosis: 115

Muhammad Al-Muhaizea Selected Research

Muhammad Al-Muhaizea Research Topics

Disease

Drug/Important Bio-Agent (IBA)